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mm. GAIT patients who did not experience OA flare, defined
as increases of (a) 15 mm in WOMAC walking pain and (b)
Likert Physician Global of Disease Severity ≥1, between screen-
ing and randomization visits had a lower placebo response rate
and may have improved ability to discriminate among treatment
groups. Response was defined as 20% improvement in summed
WOMAC Pain between randomization and 6 months of treatment,
and by OMERACT-OARSI criteria. This abstract reports differ-
ences noted in chondroitin sulfate response in these "non-flare"
patients.
Results: Results: 1583 patients were recruited to GAIT. 1221
patients (77.1%) did not have flare as defined above. While
these patients were demographically similar to the overall group,
it was noted that chondroitin sulfate response seemed more pro-
nounced in the non-flare patients that may have less advanced
disease (WOMAC Pain 125-300mm; KL Grade 2) as detailed
below:
20% WOMAC Pain Response
G CS G+CS CE PL
WOMAC Pain =300mm 64.9% 66.7% 60.5% 68.8% 59.4%
WOMAC Pain 301-400mm 63.3% 54.5% 79.2% 69.0% 49.0%
KL Grade 2 65.4% 72.9% 68.5% 74.0% 60.6%
KL Grade 3 63.4% 53.6% 60.5% 61.4% 52.8%
OMERACT-OARSI Response
G CS G+CS CE PL
WOMAC Pain =300mm 59.5% 64.3% 61.0% 65.9% 56.1%
WOMAC Pain 301-400mm 63.3% 52.3% 73.6% 69.0% 43.1%
KL Grade 2 60.2% 70.8% 69.4% 69.9% 56.8%
KL Grade 3 60.4% 50.9% 58.1% 61.4% 49.1%
Conclusions: There may be a differential pain response in GAIT
patients with features that suggest relatively milder OA. The
effect of chondroitin sulfate on OA symptoms may be more pro-
nounced in these patients. Further understanding of the biologic
mechanisms of these agents is necessary.
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Purpose: Although symptomatic and radiographic osteoarthritis
(OA) of the distal interphalangeal (DIP) joints are common,
there have been few reports concerning the correction of flexed
position and lateral (ulnar or radial) deviation using a splint. We
modified 5-sting banjo finger picks made from tin to correct the
alignment of distal phalanges (the realignment splint) for the
patients with early-phase DIP OA.
Methods: The setting was an Outpatient clinic. Fifty-two patients
with a complaint of DIP joint pain at the single finger and Kellgren
and Lawrence radiographic grade of 2 or 3 at the painful DIP joint
were prospectively randomized and divided into three groups, a
group treated with the realignment splint (n=18), a group with a
placebo splint (n=17), or a group without a splint (n=17). The trial
lasted 4 weeks. The remission scores for the daily activity in the
Australian/Canadian (AUSCAN) Index and the visual analogue
scale (VAS) for subjective DIP joint pain were compared among
the three groups at the conclusion.
Results: The AUSCAN Index at the final assessment showed
significantly greater improvement in the realignment splint group
than in the no splint (p=0.024) and placebo splint (p=0.01)
groups. Similarly, there were significant differences in the change
of VAS between the no splint and realignment splint groups
(p=0.043), and between the realignment and placebo splint
groups (p=0.013).
Fig. 1. The realignment splint.
Conclusions: Through such studies, it will be meaningful to
develop an efficacious splint for patients with hand OA to im-
prove the quality of life while simultaneously reducing costs and
complications.
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Purpose: To assess the influence of patient preference on out-
come in an RCT of intra-articular corticosteroid (IS) and tidal
irrigation (TI) in patients with knee osteoarthritis (OA) and to
identify predictors of patient preference.
Methods: A 6 month, randomised, single blind, parallel group,
clinical trial of patients recruited from Rheumatology clinics with
symptomatic knee OA. Patients were randomised to IS with
40mg triamcinolone acetonide and 2mls of 1% lignocaine or TI
irrigating the knee with 500-1000 mls of normal saline through
a 3 mm diameter trochar. The primary outcome measure for
this analysis was change in WOMAC pain score (VAS). Before
randomization, patients were asked if they had a treatment
preference and this was categorised into: no preference (NP),
received their preference (RP) or did not receive their preference
(NRP). The response to intervention was compared across the
three groups and baseline characteristics were also explored.
Results: 150 subjects were randomised (65% women) and there
were 22 drop-outs (11 in each treatment arm). 79 patients
received IS and 71 TI. The numbers in each preference group
were: RP 44, NRP 60, NP 46. Patients with NP and RP had
significantly greater improvements at 24 weeks compared to
the NRP groups (Figure 1). The NRP patients did not achieve
any benefit at 24 weeks compared to baseline. The greatest
improvements were in those with NP and who received TI, the
worst outcome in those who preferred TI but received IS.
There was no difference between the three groups in clinical
characteristics including age, BMI, duration of disease, presence
of bilateral disease, radiographic severity, presence of effusions
or baseline WOMAC score. Baseline anxiety and depression
scores (HAD) were not different between the 3 groups, neither
was their rating of helplessness using a validated questionnaire.
Women were more likely to express a treatment preference
